CG
CERE

Carmignac Gestion’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Carmignac Gestion’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-142,015
Closed -$5.81M – 189
2024
Q2 		$5.81M Hold
142,015
– – 0.1% 73
2024
Q1 		$6M Buy
142,015
+97,834
+221% +$4.11M 0.09% 69
2023
Q4 		$1.87M Buy
+44,181
New +$1.27M 0.03% 110

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return